Timofey Petrov will leave the post of General Director of Rafarma

Timofey Petrov, the General Director of Lipetsk-based Rafarma, will leave the company soon. The decision on who will take his place will be made by Rafarma's board of directors in January 2017. Petrov has been leading the company since November 2015.

Petrov's contract with Rafarma expires on December 23, and a new contract will not be signed, Petrov himself told Vademecum. According to him, his departure from the company is related to his family's decision to move abroad.

Deputy General Director Alexander Ageyev will be appointed acting General Director, says Petrov.

Rafarma's press service confirmed Petrov's desire to leave the company "due to family circumstances." However, the information that Ageyev will take Petrov's place was not confirmed by Rafarma. "The decision on the appointment of the acting General Director, as well as on the candidate for the new General Director of JSC Rafarma, will be made at the board of directors meeting in January 2017," stated the press service's response to a Vademecum inquiry. Vademecum was unable to reach Ageyev himself.

Before Rafarma, Timofey Petrov worked at Pharm-Sintez CJSC. In early 2008, he became the company's Medical Director, in 2009 – its General Director, and in April 2015 – its President.

The Rafarma plant was launched in 2014 on the territory of the "Terbuny" regional-level special economic zone in the Lipetsk region. The company produces antibiotics, anticancer drugs, and other pharmaceuticals. The enterprise was built with funds from Vnesheconombank (VEB), which invested over 100 million euros in the project. According to SPARK data, in 2015 JSC Rafarma's revenue amounted to 584 million rubles, with a net loss of 1.3 billion rubles.